Aripiprazole. (n.d.). Medline Plus. Retrieved August 12, 2023, from https://medlineplus.gov/druginfo/meds/a603012.html
Highlights of prescribing information for aripiprazole tablets. (n.d.). U.S. Food And Drug Administration. Retrieved August 12, 2023, from https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/021436s038,021713s030,021729s022,021866s023lbl.pdf
Han, C., Wang, S. M., Lee, S. J., Jun, T. Y., & Pae, C. U. (2015). Optimizing the use of aripiprazole augmentation in the treatment of major depressive disorder: from clinical trials to clinical practice. Chonnam Medical Journal, 51(2), 51-57. doi:10.4068/cmj.2015.51.2.51
Kirino, E. (2012). Efficacy and safety of aripiprazole in child and adolescent patients. European Child & Adolescent Psychiatry, 21(7), 381-392. doi:10.1007/s00787-012-0274-2
Leslie Citrome. (2006). A review of aripiprazole in the treatment of patients with schizophrenia or bipolar I disorder. CNS Spectrums, 11(7 Suppl 7), 12-21. doi:10.1017/s1092852900014107
Coustals, N., Ménard, M. L., & Cohen, D. (2021). Aripiprazole in children and adolescents. Journal of Child and Adolescent Psychopharmacology, 31(1), 1-8. doi:10.1089/cap.2020.0014
Razjouyan, K., Danesh, A., Khademi, M., Davari-Ashtiani, R., & Noorbakhsh, S. (2018). A comparative study of risperidone and aripiprazole in attention deficit hyperactivity disorder in children under six years old: A randomized double-blind study. Iranian Journal of Pediatrics, 28(5), e60087. doi:10.5812/ijp.60087